Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mastocytosis × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 41 Myelodysplastic Syndromes 18 Breast Neoplasms 18 Leukemia, Myelomonocytic, Chronic 12 Prostatic Neoplasms 10 Neoplasms 10 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Myeloproliferative Disorders 5 Multiple Myeloma 5 Lymphoma, B-Cell 5 Esophageal Neoplasms 5 Sarcoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Melanoma 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3 Squamous Cell Carcinoma of Head and Neck 3 Primary Myelofibrosis 3 Polycythemia Vera 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

midostaurin 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Watchful Waiting 1 Transplantation 1 Tacrolimus 1 Single-Cell Gene Expression Analysis 1 Radiotherapy 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Injections 1 Imatinib Mesylate 1 Dasatinib 1 Cyclophosphamide 1 Cladribine 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01333293 2016-01-18

XOLMA

University of Zurich

Phase 2/3 Completed

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡